{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T19:50:06Z","timestamp":1780516206302,"version":"3.54.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Nature Science foundation of China","doi-asserted-by":"crossref","award":["81402939"],"award-info":[{"award-number":["81402939"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Strategic Priority Research Program of the Chinese Academy of Sciences","award":["XDA12020215"],"award-info":[{"award-number":["XDA12020215"]}]},{"name":"Strategic Priority Research Program of the Chinese Academy of Sciences","award":["XDA12020107"],"award-info":[{"award-number":["XDA12020107"]}]},{"DOI":"10.13039\/501100012166","name":"National Basic Research Program of China","doi-asserted-by":"crossref","award":["2014CB541906"],"award-info":[{"award-number":["2014CB541906"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.phrs.2017.11.012","type":"journal-article","created":{"date-parts":[[2017,11,15]],"date-time":"2017-11-15T01:00:44Z","timestamp":1510707644000},"page":"443-452","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"special_numbering":"C","title":["Topical administration of reversible SAHH inhibitor ameliorates imiquimod-induced psoriasis-like skin lesions in mice via suppression of TNF-\u03b1\/IFN-\u03b3-induced inflammatory response in keratinocytes and T cell-derived IL-17"],"prefix":"10.1016","volume":"129","author":[{"given":"Ze-Min","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Ting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Xi","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Fu","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Qian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Hua","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Jun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Ping","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2017.11.012_bib0005","doi-asserted-by":"crossref","first-page":"ii30","DOI":"10.1136\/ard.2004.031120","article-title":"Psoriasis pathophysiology: current concepts of pathogenesis","volume":"64","author":"Kruegerand","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.phrs.2017.11.012_bib0010","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJMra0804595","article-title":"Psoriasis","volume":"361","author":"Nestle","year":"2009","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.phrs.2017.11.012_bib0015","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/j.jaad.2005.04.035","article-title":"Psoriasis\u2014recent advances in understanding its pathogenesis and treatment","volume":"53","author":"Kruegerand","year":"2005","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.phrs.2017.11.012_bib0020","doi-asserted-by":"crossref","first-page":"84","DOI":"10.5114\/pdia.2014.40920","article-title":"Chemokines and cytokines network in the pathogenesis of the inflammatory skin diseases: atopic dermatitis, psoriasis and skin mastocytosis","volume":"31","author":"Nedoszytko","year":"2014","journal-title":"Adv. Dermatol. Allergol.\/Post\u0229py Dermatologii i Alergologii"},{"key":"10.1016\/j.phrs.2017.11.012_bib0025","doi-asserted-by":"crossref","first-page":"S460","DOI":"10.1067\/mai.2003.108","article-title":"Cytokines and chemokines","volume":"111","author":"Borishand","year":"2003","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.phrs.2017.11.012_bib0030","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/0140-6736(91)92168-2","article-title":"Keratinocytes as initiators of inflammation","volume":"337","author":"Barker","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2017.11.012_bib0035","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jep.2012.08.049","article-title":"Illicium verum extract inhibits TNF-\u03b1- and IFN-\u03b3-induced expression of chemokines and cytokines in human keratinocytes","volume":"144","author":"Sung","year":"2012","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.phrs.2017.11.012_bib0040","first-page":"469","article-title":"Curcumin attenuates the expression of IL-1beta, IL-6, and TNF-alpha as well as cyclin E in TNF-alpha-treated HaCaT cells; NF-kappaB and MAPKs as potential upstream targets","volume":"19","author":"Cho","year":"2007","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.phrs.2017.11.012_bib0045","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.biocel.2008.10.022","article-title":"Interplay between keratinocytes and immune cells\u2014recent insights into psoriasis pathogenesis","volume":"41","author":"Toneland","year":"2009","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.phrs.2017.11.012_bib0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1067\/mjd.2002.120568","article-title":"The immunologic basis for the treatment of psoriasis with new biologic agents","volume":"46","author":"Krueger","year":"2002","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.phrs.2017.11.012_bib0055","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1349-7006.2006.00244.x","article-title":"ERK MAP kinase in G cell cycle progression and cancer","volume":"97","author":"Torii","year":"2006","journal-title":"Cancer Sci."},{"key":"10.1016\/j.phrs.2017.11.012_bib0060","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1242\/dmm.009092","article-title":"Putting together the psoriasis puzzle: an update on developing targeted therapies","volume":"5","author":"Johnson-Huang","year":"2012","journal-title":"Dis. Models Mech."},{"key":"10.1016\/j.phrs.2017.11.012_bib0065","first-page":"1092","article-title":"Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways","volume":"159","author":"Nograles","year":"2008","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.phrs.2017.11.012_bib0070","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jaci.2012.04.024","article-title":"IL-17A is essential for cell activation and inflammatory gene circuits in psoriasis","volume":"130","author":"Krueger","year":"2012","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.phrs.2017.11.012_bib0075","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1096\/fasebj.10.4.8647346","article-title":"S-Adenosylmethionine and methylation","volume":"10","author":"Chiang","year":"1996","journal-title":"FASEB J."},{"key":"10.1016\/j.phrs.2017.11.012_bib0080","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.clim.2013.02.018","article-title":"Critical role of transmethylation in TLR signaling and systemic lupus erythematosus","volume":"147","author":"Tardif","year":"2013","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.phrs.2017.11.012_bib0085","doi-asserted-by":"crossref","first-page":"10997","DOI":"10.1016\/S0021-9258(17)44376-6","article-title":"Measurements of S-adenosylmethionine and L-homocysteine metabolism in cultured human lymphoid cells","volume":"258","author":"German","year":"1983","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2017.11.012_bib0090","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/08916934.2012.732133","article-title":"Lupus autoimmunity altered by cellular methylation metabolism","volume":"46","author":"Yang","year":"2013","journal-title":"Autoimmunity"},{"key":"10.1016\/j.phrs.2017.11.012_bib0095","doi-asserted-by":"crossref","first-page":"526","DOI":"10.4049\/jimmunol.151.1.526","article-title":"Immunosuppression mediated by an inhibitor of S-adenosyl-L-homocysteine hydrolase. Prevention and treatment of collagen-induced arthritis","volume":"151","author":"Wolos","year":"1993","journal-title":"J. Immunol."},{"key":"10.1016\/j.phrs.2017.11.012_bib0100","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0022-3565(24)29669-5","article-title":"S-Adenosyl-L-homocysteine hydrolase inhibitor mediates immunosuppressive effects in vivo: suppression of delayed type hypersensitivity ear swelling and peptidoglycan polysaccharide-induced arthritis","volume":"296","author":"Saso","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phrs.2017.11.012_bib0105","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/cimm.1993.1165","article-title":"Immunomodulation by an inhibitor of S-adenosyl-L-homocysteine hydrolase: inhibition of in vitro and in vivo allogeneic responses","volume":"149","author":"Wolos","year":"1993","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.phrs.2017.11.012_bib0110","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1124\/jpet.104.080416","article-title":"Inhibition of S-adenosyl-L-homocysteine hydrolase induces immunosuppression","volume":"313","author":"Wu","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phrs.2017.11.012_bib0115","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1124\/jpet.105.093369","article-title":"S-adenosyl-L-homocysteine hydrolase inactivation curtails ovalbumin-induced immune responses","volume":"316","author":"Fu","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phrs.2017.11.012_bib0120","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1124\/jpet.106.107185","article-title":"A reversible S-adenosyl-L-homocysteine hydrolase inhibitor ameliorates experimental autoimmune encephalomyelitis by inhibiting T cell activation","volume":"319","author":"Fu","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phrs.2017.11.012_bib0125","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/aps.2013.167","article-title":"Therapeutic effects of DZ2002, a reversible SAHH inhibitor, on lupus-prone NZBxNZW F1 mice via interference with TLR-mediated APC response","volume":"35","author":"He","year":"2014","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.phrs.2017.11.012_bib0130","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.intimp.2015.10.023","article-title":"Icariin inhibits TNF-\u03b1\/IFN-\u03b3 induced inflammatory response via inhibition of the substance P and p38-MAPK signaling pathway in human keratinocytes","volume":"29","author":"Kong","year":"2015","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.phrs.2017.11.012_bib0135","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1084\/jem.20130291","article-title":"Epidermal IL-15R\u03b1 acts as an endogenous antagonist of psoriasiform inflammation in mouse and man","volume":"210","author":"Bouchaud","year":"2013","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.phrs.2017.11.012_bib0140","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/exd.12448","article-title":"Skin-penetrating methotrexate alleviates imiquimod-induced psoriasiform dermatitis via decreasing IL-17-producing gamma delta T cells","volume":"23","author":"Byamba","year":"2014","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.phrs.2017.11.012_bib0145","doi-asserted-by":"crossref","first-page":"7687","DOI":"10.1038\/ncomms8687","article-title":"Adiponectin regulates psoriasiform skin inflammation by suppressing IL-17 production from gammadelta-T cells","volume":"6","author":"Shibata","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2017.11.012_bib0150","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1440-0960.2004.00030.x","article-title":"Psoriasis induced by topical imiquimod","volume":"45","author":"Wu","year":"2004","journal-title":"Australas. J. Dermatol."},{"key":"10.1016\/j.phrs.2017.11.012_bib0155","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1111\/j.1365-4632.2006.02980.x","article-title":"Generalized psoriasis induced by topical treatment of actinic keratosis with imiquimod","volume":"45","author":"Fanti","year":"2006","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.phrs.2017.11.012_bib0160","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","article-title":"Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis","volume":"182","author":"Fits","year":"2009","journal-title":"J. Immunol."},{"issue":"Suppl. 2","key":"10.1016\/j.phrs.2017.11.012_bib0165","first-page":"ii30","article-title":"Psoriasis pathophysiology: current concepts of pathogenesis","volume":"64","author":"Bowcook","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.phrs.2017.11.012_bib0170","article-title":"Upregulation of PI3K\/AKT\/mTOR, FABP5 and PPAR\u03b2\/\u03b4 in human psoriasis and imiquimod-induced murine psoriasiform dermatitis model","volume":"96","author":"Chamcheu","year":"2016","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.phrs.2017.11.012_bib0175","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/ncomms2566","article-title":"Aldara activates TLR7-independent immune defence","volume":"4","author":"Walter","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.phrs.2017.11.012_bib0180","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.jid.2016.10.024","article-title":"The snowballing literature on imiquimod-induced skin inflammation in mice: a critical appraisal","volume":"137","author":"Hawkes","year":"2017","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.phrs.2017.11.012_bib0185","series-title":"Pathogenesis of Psoriasis: The Role of Pro-Inflammatory Cytokines Produced by Keratinocytes","author":"Balato","year":"2012"},{"key":"10.1016\/j.phrs.2017.11.012_bib0190","doi-asserted-by":"crossref","first-page":"32633","DOI":"10.1074\/jbc.M400642200","article-title":"Effects of tumor necrosis factor-alpha (TNF alpha) in epidermal keratinocytes revealed using global transcriptional profiling","volume":"279","author":"Banno","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2017.11.012_bib0195","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1038\/sj.onc.1207317","article-title":"Expression of both TNF-alpha receptor subtypes is essential for optimal skin tumour development","volume":"23","author":"Arnott","year":"2004","journal-title":"Oncogene"},{"issue":"Suppl","key":"10.1016\/j.phrs.2017.11.012_bib0200","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jaut.2005.09.025","article-title":"Immunopathogenesis of psoriasis: recent insights on the role of adaptive and innate immunity","volume":"25","author":"Bachelez","year":"2005","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.phrs.2017.11.012_bib0205","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.it.2012.11.005","article-title":"The IL-23\/T17 pathogenic axis in psoriasis is amplified by keratinocyte responses","volume":"34","author":"Lowes","year":"2013","journal-title":"Trends Immunol."},{"key":"10.1016\/j.phrs.2017.11.012_bib0210","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/jid.2010.340","article-title":"Integrative responses to IL-17 and TNF-alpha in human keratinocytes account for key inflammatory pathogenic circuits in psoriasis","volume":"131","author":"Chiricozzi","year":"2011","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.phrs.2017.11.012_bib0215","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/ni.f.213","article-title":"Orchestrating the orchestrators: chemokines in control of T cell traffic","volume":"9","author":"Bromley","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.phrs.2017.11.012_bib0220","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMra052723","article-title":"The many roles of chemokines and chemokine receptors in inflammation","volume":"354","author":"Charoand","year":"2006","journal-title":"N. Engl. J. Med."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661817304504?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661817304504?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T00:49:02Z","timestamp":1750985342000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661817304504"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":44,"alternative-id":["S1043661817304504"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2017.11.012","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topical administration of reversible SAHH inhibitor ameliorates imiquimod-induced psoriasis-like skin lesions in mice via suppression of TNF-\u03b1\/IFN-\u03b3-induced inflammatory response in keratinocytes and T cell-derived IL-17","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2017.11.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}